13F FilingMay 28, 2026by InvestLog AI

Duquesne Family Office Q1 2026 13F: top 20 holdings and quarterly changes德鲁肯米勒 / Duquesne Q1 2026 13F:前 20 大持仓与季度变化

Duquesne Family Office 13F snapshot: Q1 2026

Duquesne Family Office's latest 13F shows about $3.17B of reported US-listed long equity/ETF positions across 68 names.

How to read it

  • Top 5 positions are 40.2% of reported 13F value; top 20 are 76.1%; the top 20 are the cleanest view of core exposure.
  • Quarter-over-quarter, the filing shows 30 new positions, 9 increased positions, 19 decreased positions, and 22 full exits.
  • The portfolio is moderately diversified; the top 20 show the main exposure, while new/increased/closed positions capture the marginal move.
  • Top 20 holdings

    1. NTRA (Natera Inc): $612.7M, 19.3% of 13F, 3,063,606 shares

    2. INSM (Insmed Inc): $188.7M, 5.9% of 13F, 1,154,090 shares

    3. TSM (Taiwan Semiconductor Manufac): $167.4M, 5.3% of 13F, 495,280 shares

    4. RSP (Invesco Exchange Traded Fd T): $157.6M, 5.0% of 13F, 821,000 shares

    5. YPF (Ypf Sociedad Anonima): $149.6M, 4.7% of 13F, 3,235,962 shares

    6. EWZ (Ishares Inc): $131.9M, 4.2% of 13F, 3,436,170 shares

    7. TBBB (Bbb Foods Inc): $110.0M, 3.5% of 13F, 3,109,202 shares

    8. AA (Alcoa Corp): $99.1M, 3.1% of 13F, 1,493,390 shares

    9. NAMS (Newamsterdam Pharma Company): $98.3M, 3.1% of 13F, 3,070,146 shares

    10. SE (Sea Ltd): $91.1M, 2.9% of 13F, 1,099,905 shares

    11. STM (Stmicroelectronics N V): $90.3M, 2.8% of 13F, 2,612,880 shares

    12. WWD (Woodward Inc): $75.6M, 2.4% of 13F, 211,355 shares

    13. TEVA (Teva Pharmaceutical Inds Ltd): $71.6M, 2.3% of 13F, 2,377,285 shares

    14. ROKU (Roku Inc): $71.0M, 2.2% of 13F, 750,190 shares

    15. AVGO (Broadcom Inc): $60.6M, 1.9% of 13F, 195,955 shares

    16. SPY (State Str Spdr S&P 500 Etf T): $58.5M, 1.8% of 13F, 90,000 shares

    17. CPNG (Coupang Inc): $50.4M, 1.6% of 13F, 2,667,485 shares

    18. OPCH (Option Care Health Inc): $50.3M, 1.6% of 13F, 1,868,550 shares

    19. CRH (Crh Plc): $39.7M, 1.3% of 13F, 377,555 shares

    20. FIGR (Figure Technology Solutio): $39.1M, 1.2% of 13F, 1,150,415 shares

    Major quarterly changes

    New positions (30)

  • AVGO: (Broadcom Inc): $60.6M
  • ARGT: (Global X Fds): $36.2M
  • CAI: (Caris Life Sciences Inc): $33.9M
  • RVMD: (Revolution Medicines Inc): $30.7M
  • SNDK: (Sandisk Corp): $24.2M
  • HUM: (Humana Inc): $23.8M
  • Increased (9)

  • YPF: (Ypf Sociedad Anonima): shares +433%, value change $127.6M
  • STM: (Stmicroelectronics N V): shares +238%, value change $70.2M
  • NTRA: (Natera Inc): shares +22%, value change $37.4M
  • TBBB: (Bbb Foods Inc): shares +16%, value change $20.6M
  • ADMA: (Adma Biologics Inc): shares +513%, value change $9.3M
  • ROKU: (Roku Inc): shares +29%, value change $7.7M
  • Decreased (19)

  • TEVA: (Teva Pharmaceutical Inds Ltd): shares -60%, value change -$111.8M
  • CPNG: (Coupang Inc): shares -61%, value change -$109.4M
  • WWD: (Woodward Inc): shares -64%, value change -$103.0M
  • MELI: (Mercadolibre Inc): shares -94%, value change -$90.2M
  • INSM: (Insmed Inc): shares -22%, value change -$69.2M
  • RSP: (Invesco Exchange Traded Fd T): shares -30%, value change -$67.3M
  • Closed (22)

  • XLF: (Select Sector Spdr Tr): $301.0M
  • GOOGL: (Alphabet Inc): $120.5M
  • COGT: (Cogent Biosciences Inc): $78.7M
  • ENTG: (Entegris Inc): $71.1M
  • DOCU: (Docusign Inc): $69.7M
  • EEM: (Ishares Tr): $49.4M
  • Note: 13F covers quarter-end US-listed long equity/ETF holdings only. It excludes shorts, derivatives, cash, and intra-quarter trading. Informational research only, not investment advice.

    德鲁肯米勒 / Duquesne 13F 持仓快照:Q1 2026

    德鲁肯米勒 / Duquesne 最新 13F 显示,2026 年第 1 季度披露的美股多头持仓市值约 $3.17B,覆盖 68 个标的。

    怎么读

  • 前 5 大持仓占 40.2%,前 20 大持仓占 76.1%,用前 20 大持仓看核心风险暴露更直接。
  • 本季度披露中,新建仓 30 个、加仓 9 个、减仓 19 个、清仓 22 个。
  • 组合分散度适中,前 20 大持仓能展示主线,但仍需结合新增、加仓和清仓观察边际变化。
  • 前 20 大持仓

    1. NTRA(Natera Inc):$612.7M,占 13F 19.3%,3,063,606 股

    2. INSM(Insmed Inc):$188.7M,占 13F 5.9%,1,154,090 股

    3. TSM(台积电):$167.4M,占 13F 5.3%,495,280 股

    4. RSP(Invesco Exchange Traded Fd T):$157.6M,占 13F 5.0%,821,000 股

    5. YPF(阿根廷YPF):$149.6M,占 13F 4.7%,3,235,962 股

    6. EWZ(Ishares Inc):$131.9M,占 13F 4.2%,3,436,170 股

    7. TBBB(Bbb Foods Inc):$110.0M,占 13F 3.5%,3,109,202 股

    8. AA(美国铝业公司):$99.1M,占 13F 3.1%,1,493,390 股

    9. NAMS(Newamsterdam Pharma Company):$98.3M,占 13F 3.1%,3,070,146 股

    10. SE(Sea集团):$91.1M,占 13F 2.9%,1,099,905 股

    11. STM(意法半导体):$90.3M,占 13F 2.8%,2,612,880 股

    12. WWD(Woodward Inc):$75.6M,占 13F 2.4%,211,355 股

    13. TEVA(梯瓦制药公司):$71.6M,占 13F 2.3%,2,377,285 股

    14. ROKU(Roku Inc):$71.0M,占 13F 2.2%,750,190 股

    15. AVGO(博通):$60.6M,占 13F 1.9%,195,955 股

    16. SPY(标普500ETF):$58.5M,占 13F 1.8%,90,000 股

    17. CPNG(Coupang Inc):$50.4M,占 13F 1.6%,2,667,485 股

    18. OPCH(Option Care Health Inc):$50.3M,占 13F 1.6%,1,868,550 股

    19. CRH(CRH水泥):$39.7M,占 13F 1.3%,377,555 股

    20. FIGR(Figure Technology Solutio):$39.1M,占 13F 1.2%,1,150,415 股

    本季度主要变化

    新建仓 (30)

  • AVGO: (博通):$60.6M
  • ARGT: (Global X Fds):$36.2M
  • CAI: (Caris Life Sciences Inc):$33.9M
  • RVMD: (Revolution Medicines Inc):$30.7M
  • SNDK: (闪迪公司):$24.2M
  • HUM: (休曼纳公司):$23.8M
  • 加仓 (9)

  • YPF: (阿根廷YPF):持股数 +433%,市值变化约 $127.6M
  • STM: (意法半导体):持股数 +238%,市值变化约 $70.2M
  • NTRA: (Natera Inc):持股数 +22%,市值变化约 $37.4M
  • TBBB: (Bbb Foods Inc):持股数 +16%,市值变化约 $20.6M
  • ADMA: (Adma Biologics Inc):持股数 +513%,市值变化约 $9.3M
  • ROKU: (Roku Inc):持股数 +29%,市值变化约 $7.7M
  • 减仓 (19)

  • TEVA: (梯瓦制药公司):持股数 -60%,市值变化约 -$111.8M
  • CPNG: (Coupang Inc):持股数 -61%,市值变化约 -$109.4M
  • WWD: (Woodward Inc):持股数 -64%,市值变化约 -$103.0M
  • MELI: (Mercadolibre Inc):持股数 -94%,市值变化约 -$90.2M
  • INSM: (Insmed Inc):持股数 -22%,市值变化约 -$69.2M
  • RSP: (Invesco Exchange Traded Fd T):持股数 -30%,市值变化约 -$67.3M
  • 清仓 (22)

  • XLF: (金融板块ETF):$301.0M
  • GOOGL: (谷歌):$120.5M
  • COGT: (Cogent Biosciences Inc):$78.7M
  • ENTG: (英特格):$71.1M
  • DOCU: (Docusign Inc):$69.7M
  • EEM: (新兴市场ETF):$49.4M
  • 说明:13F 只覆盖季度末美国上市股票/ETF 的多头仓位,不包括空头、衍生品、现金和季度内交易路径;本文用于研究参考,不构成投资建议。

    This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考,不构成投资建议。